Education
About Us
Working with TipRanks
Follow Us
Kraig Biocraft Laboratories (KBLB)
:KBLB
RESEARCH TOOLSreports
Total Valuation
Kraig Biocraft Laboratories has a market cap or net worth of $93.94M. The enterprise value is ―.
Market Cap$93.94M
Enterprise Value―
Share Statistics
Kraig Biocraft Laboratories has 1,043,826,800 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,043,826,800
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Kraig Biocraft Laboratories’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee0.00
Profits Per Employee-81.89K
Employee Count37
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Kraig Biocraft Laboratories is ―. Kraig Biocraft Laboratories’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Kraig Biocraft Laboratories had revenue of 0.00 and earned -3.03M in profits. Earnings per share was 0.00.
Revenue0.00
Gross Profit-27.62K
Operating Income-2.61M
Pretax Income-3.03M
Net Income-3.03M
EBITDA-2.59M
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was -1.65M and capital expenditures 0.00, giving a free cash flow of -2.17M billion.
Operating Cash Flow-1.65M
Free Cash Flow-2.17M
Free Cash Flow per Share>-0.01
Dividends & Yields
Kraig Biocraft Laboratories pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.85
52-Week Price Change-10.00%
50-Day Moving Average0.09
200-Day Moving Average0.10
Relative Strength Index (RSI)57.46
Average Volume (3m)619.73K
Important Dates
Kraig Biocraft Laboratories upcoming earnings date is Aug 10, 2023, TBA Not Confirmed.
Last Earnings DateMay 12, 2023
Next Earnings DateAug 10, 2023
Ex-Dividend Date―
Financial Position
Kraig Biocraft Laboratories as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Kraig Biocraft Laboratories has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate―
Enterprise Valuation
Kraig Biocraft Laboratories EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Kraig Biocraft Laboratories has $1.19M in cash and marketable securities with $322.00K in debt, giving a net cash position of $527.04K billion.
Cash & Marketable Securities$1.19M
Total Debt$322.00K
Net Cash$527.04K
Net Cash Per Share<$0.01
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Kraig Biocraft Laboratories is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―